ATE426808T1 - Proteininteraktionsdifferenzabbildung - Google Patents

Proteininteraktionsdifferenzabbildung

Info

Publication number
ATE426808T1
ATE426808T1 AT03766029T AT03766029T ATE426808T1 AT E426808 T1 ATE426808 T1 AT E426808T1 AT 03766029 T AT03766029 T AT 03766029T AT 03766029 T AT03766029 T AT 03766029T AT E426808 T1 ATE426808 T1 AT E426808T1
Authority
AT
Austria
Prior art keywords
protein interaction
multicomponent
complex
interaction difference
elution
Prior art date
Application number
AT03766029T
Other languages
English (en)
Inventor
William Rich
Egisto Boschetti
Lee Lomas
Tai-Tung Yip
Original Assignee
Bio Rad Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Laboratories filed Critical Bio Rad Laboratories
Application granted granted Critical
Publication of ATE426808T1 publication Critical patent/ATE426808T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT03766029T 2002-07-24 2003-07-23 Proteininteraktionsdifferenzabbildung ATE426808T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39864102P 2002-07-24 2002-07-24
US44553603P 2003-02-06 2003-02-06

Publications (1)

Publication Number Publication Date
ATE426808T1 true ATE426808T1 (de) 2009-04-15

Family

ID=30773100

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03766029T ATE426808T1 (de) 2002-07-24 2003-07-23 Proteininteraktionsdifferenzabbildung

Country Status (7)

Country Link
US (1) US7348184B2 (de)
EP (1) EP1552302B1 (de)
JP (1) JP4587954B2 (de)
AT (1) ATE426808T1 (de)
AU (1) AU2003256806A1 (de)
DE (1) DE60326864D1 (de)
WO (1) WO2004009798A2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7402397B2 (en) 2002-05-21 2008-07-22 Monogram Biosciences, Inc. Detecting and profiling molecular complexes
US20040229294A1 (en) 2002-05-21 2004-11-18 Po-Ying Chan-Hui ErbB surface receptor complexes as biomarkers
EP1681983A4 (de) 2003-10-14 2008-12-10 Monogram Biosciences Inc Rezeptor-tyrosin-kinase-signalpfad-analyse für diagnose und therapie
US7707134B2 (en) * 2005-01-14 2010-04-27 Siemens Medical Solutions Usa, Inc. System and method for molecular diagnosis of depression based on boosting classification
US7672916B2 (en) * 2005-08-16 2010-03-02 The Trustees Of Columbia University In The City Of New York Methods, systems, and media for music classification
US20080023630A1 (en) * 2005-11-22 2008-01-31 Ciphergen Biosystems Inc. Polymer probe doped with conductive material for mass spectrometry
KR20140021725A (ko) 2005-12-13 2014-02-20 엑스테라 메디컬 코퍼레이션 혈액으로부터 병원성 미생물, 염증 세포 또는 염증 단백질의 체외 제거를 위한 방법
AU2007209980A1 (en) * 2006-01-27 2007-08-09 Eastern Virginia Medical School Proteomic fingerprinting of human IVF-derived embryos: identification of biomarkers of developmental potential
CN102246259B (zh) * 2008-10-10 2015-04-08 卓漂仪谱公司 化学和生物样品分离的方法和装置
WO2011068897A1 (en) 2009-12-01 2011-06-09 Exthera Medical, Llc Method for removing cytokines from blood with surface immobilized polysaccharides
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
US9746458B2 (en) * 2011-04-27 2017-08-29 Loma Linda University Medical Center Dynactin subunit p62 biomarker for neurological conditions
RU2666989C2 (ru) * 2012-06-07 2018-09-13 Сомалоджик, Инк. Мультиплексные анализы на основе аптамеров
EP2861273B1 (de) 2012-06-13 2017-08-23 ExThera Medical Corporation Verwendung von heparin und kohlenhydraten zur behandlung von krebs
US10942184B2 (en) 2012-10-23 2021-03-09 Caris Science, Inc. Aptamers and uses thereof
JP6404822B2 (ja) 2012-10-23 2018-10-17 カリス ライフ サイエンシズ スウィッツァーランド ホールディングス ゲーエムベーハー アプタマーおよびその使用
EP2935628B1 (de) 2012-12-19 2018-03-21 Caris Life Sciences Switzerland Holdings GmbH Zusammensetzungen und verfahren für aptamer-screening
EP3013445B1 (de) 2013-06-24 2019-11-06 ExThera Medical Corporation Blutfiltrationssystem mit mannosebeschichtetem substrat
CN105705177B (zh) 2013-11-08 2019-10-22 艾克塞拉医疗公司 使用吸附介质诊断感染性疾病的方法
CA2946294C (en) 2014-04-24 2023-03-21 Exthera Medical Corporation Method for removing bacteria from blood using high flow rate
AU2015321601B2 (en) 2014-09-22 2020-04-23 Exthera Medical Corporation Wearable hemoperfusion device
EP3112869A1 (de) * 2015-06-30 2017-01-04 IMEC vzw Sensorvorrichtung
US10386351B2 (en) 2015-12-07 2019-08-20 Nanohmics, Inc. Methods for detecting and quantifying analytes using gas species diffusion
US10386365B2 (en) 2015-12-07 2019-08-20 Nanohmics, Inc. Methods for detecting and quantifying analytes using ionic species diffusion
US11988662B2 (en) 2015-12-07 2024-05-21 Nanohmics, Inc. Methods for detecting and quantifying gas species analytes using differential gas species diffusion
US10786615B2 (en) 2016-03-02 2020-09-29 Exthera Medical Corporation Method for treating drug intoxication
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
ITUA20163876A1 (it) * 2016-05-27 2017-11-27 Univ Del Salento Biorecettore per ioni metallici.
US20210072255A1 (en) 2016-12-16 2021-03-11 The Brigham And Women's Hospital, Inc. System and method for protein corona sensor array for early detection of diseases
WO2020096631A2 (en) 2018-11-07 2020-05-14 Seer, Inc. Compositions, methods and systems for protein corona analysis and uses thereof
MX2021013515A (es) 2019-05-16 2022-01-04 Exthera Medical Corp Metodo para modular la estructura del glucocaliz endotelial.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234811A (en) * 1991-09-27 1993-08-10 The Scripps Research Institute Assay for a new gaucher disease mutation
US5571729A (en) * 1992-06-17 1996-11-05 Wako Pure Chemical Industries, Ltd. Process for separating complex
DE69432791T2 (de) * 1993-05-28 2004-06-03 Baylor College Of Medicine, Houston Verfahren und massenspektrometer zur desorption und ionisierung von analyten
NZ516848A (en) * 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
WO1999019510A1 (en) * 1997-10-10 1999-04-22 President And Fellows Of Harvard College Surface-bound, double-stranded dna protein arrays
US6265715B1 (en) * 1998-02-02 2001-07-24 Helene Perreault Non-porous membrane for MALDI-TOFMS
AU4338300A (en) * 1999-04-09 2000-11-14 Geron Corporation A second mammalian tankyrase
WO2001088528A2 (en) * 2000-05-12 2001-11-22 Admetric Biochem Inc. High throughput chromatographic systems
US20030091976A1 (en) 2001-11-14 2003-05-15 Ciphergen Biosystems, Inc. Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry

Also Published As

Publication number Publication date
AU2003256806A8 (en) 2004-02-09
WO2004009798A2 (en) 2004-01-29
JP2005534043A (ja) 2005-11-10
DE60326864D1 (de) 2009-05-07
US20040146937A1 (en) 2004-07-29
US7348184B2 (en) 2008-03-25
EP1552302A4 (de) 2006-09-13
WO2004009798A3 (en) 2004-10-07
JP4587954B2 (ja) 2010-11-24
EP1552302B1 (de) 2009-03-25
AU2003256806A1 (en) 2004-02-09
EP1552302A2 (de) 2005-07-13

Similar Documents

Publication Publication Date Title
ATE426808T1 (de) Proteininteraktionsdifferenzabbildung
EP1545582A4 (de) Von amyolid-beta abgeleitete diffundierbare liganden (addls), addl-ersatzstoffe, addl-bindungsmoleküle und verwendungen davon
WO2003072803A3 (en) Nanostructures containing antibody assembly units
NO996243L (no) Retentatkromatografi og proteinchipsrekker med anvendelse innen biologi og medisin
DK2316852T3 (da) Stabiliserede enkeltdomæne-antistoffer
DK0600866T3 (da) Præparater og fremgangsmåder til identifikation af biologisk aktive molekyler
DE59603145D1 (de) Vorrichtung zur Zugabe von Reinigungsmitteln, insbesondere für Geschirrspülmaschinen
DE60211651D1 (de) Proteom-analyseverfahren
DE60035434D1 (de) Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken
AU2003229544A1 (en) A method for testing the interaction between at least one liquid sample and a respective solid sample.
WO2002014351A3 (en) α7 NICOTINIC RECEPTOR PEPTIDES AS LIGANDS FOR β AMYLOID P EPTIDES
NO20021787L (no) Fremgangsmåte for bestemmelse av stoffer ved hjelp av evaneschensfeltfremgangsmåten
WO2003072595A3 (en) Methods and products based on oligomerization of stress proteins
WO1999030165A3 (en) Processes for identifying a solvent condition suitable for determining a biophysical property of a protein
DK1456404T3 (da) Fremgangsmåde til at bestemme difibrotids biologiske aktivitet
NL194335B (nl) Werkwijze voor het bepalen van de concentratie van een anti-microbiÙle verbinding in een monster.
DE69005088D1 (de) Vibrierende seismische Quelle, insbesondere anwendbar in Bohrlöchern.
EP1147129A4 (de) Saccharide gekoppelt an substanzen, die zelloberflächenpeptide oder proteine binden.
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
NO20025738D0 (no) Metode
WO2004083241A3 (en) Btc-interacting proteins and use thereof
ATA13642000A (de) Vorrichtung zum lageverändern und feststellen von teilen, z.b. lordosenstützen, von möbeln zum sitzen und/oder liegen
NO20052495L (no) Induserbar ligand for alfa1 beta1 integrin og anvendelse derav.
WO2003098182A3 (de) Verfahren zur quantifizierung von molekülen
ES2097158T3 (es) Ensayo funcional para la determinacion de la actividad de proteina s.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties